Open Access Articles

Journal Club
Open Access Article
Patricia Potter
Teresa Deshields
Joyce Divanbeigi
Julie Berger
Doreen Cipriano
Lori Norris
Sarah Olsen
CJON 2010, 14(5), E56-E62 DOI: 10.1188/10.CJON.E56-E62
This descriptive, cross-sectional survey was conducted in inpatient nursing units and outpatient clinics in a cancer center in the midwestern United States. The sample of 153 healthcare providers included RNs, medical assistants, and radiology technicians. The fourth revision of the 30-item...
0
No votes yet
Ausanee Wanchai
Jane M. Armer
Bob R. Stewart
CJON 2010, 14(4), E45-E55 DOI: 10.1188/10.CJON.E45-E55
Patients with breast cancer use complementary and alternative medicine (CAM) despite the fact that no studies have shown altered disease progression attributable to CAM use. The purpose of this systematic review is to summarize research as it relates to CAM use among women with breast cancer. Among...
0
No votes yet
Cindy Tofthagen
CJON 2010, 14(3), E22-E28 DOI: 10.1188/10.CJON.E22-E28
Peripheral neuropathies are a common side effect of certain types of chemotherapy drugs, including taxanes, platinum-based drugs, vinca alkaloids, and thalidomide. Neuropathies may last for months or years following treatment and can impact functional performance and quality of life. The purpose of...
0
No votes yet
Journal Club
Open Access Article
Wendy H. Vogel
CJON 2010, 14(2), E10-E21 DOI: 10.1188/10.CJON.E10-E21
Many cancer therapies administered by IV infusion, including monoclonal antibodies, have the potential for infusion reactions. All infusion reactions involve the immune system; however, some (anaphylactic) are allergic in nature and usually are mediated by immunoglobulin E (lgE), whereas others (...
0
No votes yet
Article
Open Access Article
Cynthia F. Cramer
CJON 2010, 14(1), 53-56 DOI: 10.1188/10.CJON.53-56
Oncology nurses are expected to be knowledgeable in dealing with palliative care and end-of-life issues. However, patients with advanced cancer often are not offered palliative care until they are approaching the very end of their lives. Oncology nurses need to step up as patient advocates. They...
0
No votes yet
Carolyn Spence Cagle
Jo Nell Wells
CJON 2010, 14(1), E1-E9 DOI: 10.1188/10.CJON.E1-E9
Cancer caregivers in Mexican American families experience role-related challenges influenced by limited healthcare literacy. The lack of functional health literacy becomes complex when Mexican Americans have limited English proficiency (LEP) and cultural beliefs that contrast with those of the...
0
No votes yet
Journal Club
Open Access Article
Michelle Kolb
CJON 2009, 13(6), E30-E40 DOI: 10.1188/09.CJON.E30-E40
The increasing survival rate from pediatric cancer has been one of the greatest accomplishments in the medical world in the 20th century. However, as young adult survivors move into adulthood, they must face the long-term side effects of their treatments. For such individuals, the transition to...
0
No votes yet
Deanna Sanchez Yamamoto
Pamela Hallquist Viale
CJON 2009, 13(5), E18-E29 DOI: 10.1188/09.CJON.E18-E29
Aromatase inhibitors (AIs) have become integral to the treatment of women with breast cancer and are the treatment of choice in postmenopausal women who have tumors that are estrogen receptor positive. The depletion of estrogen seen with AI therapy is significant and translates to beneficial tumor...
0
No votes yet
Guiyun Zhou
Jill Stoltzfus
Beth Ann Swan
CJON 2009, 13(4), E3-E17 DOI: 10.1188/09.CJON.E3-E17
Vitamin D deficiency is common in the general public and in patients with cancer. Optimizing vitamin D intake is increasingly recognized in cancer risk reduction, particularly in decreasing colorectal cancer risk. Therefore, summarizing the current evidence to promote best practices related to...
0
No votes yet
Nina N. Grenon
Jennifer Chan
CJON 2009, 13(3), 285-296 DOI: 10.1188/09.CJON.285-296
This article will provide an overview of the principal toxicities associated with commonly used chemotherapy treatment regimens for metastatic colorectal cancer (mCRC) and explore the role of the oncology nurse in the management of treatment-associated toxicity. Although patients with mCRC have...
0
No votes yet